Fundz Deep Dive
Everything you need to win Algernon Pharmaceuticals — in one platform.
Who to reach, what to say, and why now on Algernon Pharmaceuticals — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Algernon Pharmaceuticals — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Contract Type
partnership
VancouverBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Algernon Pharmaceuticals Inc. has announced a non-brokered private placement for gross proceeds of $250,000. Each unit will consist of one common share and one common share purchase warrant, with the offering expected to close on July 20, 2024. The company plans to use the proceeds for working capital purposes.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months